Pharmacodynamics of anticholinergic agents measured by ambulatory urodynamic monitoring: A study of methodology

Neurourology and Urodynamics

Volumn 18, Issue 3, 1999, Pages 223-234

  Rosario, Derek J ^a,b   Smith, David J ^a   Radley, Stephen C ^a   Chapple, Christopher R ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

Ambulatory monitoring; Anticholinergics; Detrusor instability; Incontinence; Urodynamics

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; DARIFENACIN; PLACEBO;

AMBULATORY MONITORING; ANTICHOLINERGIC EFFECT; ARTICLE; BLADDER CONTRACTION; BLADDER PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; CYSTOMETRY; DETRUSOR DYSSYNERGIA; DETRUSOR MUSCLE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DYSURIA; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; MICTURITION; URODYNAMICS;

BENZOFURANS; CHOLINERGIC ANTAGONISTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MONITORING, AMBULATORY; PATIENT ACCEPTANCE OF HEALTH CARE; PROSPECTIVE STUDIES; PYRROLIDINES; URINARY BLADDER; URINATION DISORDERS; URODYNAMICS;

EID: 0032907382     PISSN: 07332467     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6777(1999)18:3<223::AID-NAU9>3.0.CO;2-6     Document Type: Article

References (16)

1. Abrams P, Blavias JG, Stanton SL, Anderson JT. 1988. The standardisation of terminology of lower urinary tract function. Scand J Urol Nephrol suppl 114:5-19.
2. Bent AE. 1989. Aetiology and management of detrusor instability and mixed incontinence. Obstet Gynecol Clin North Am 16:853-68.
3. Bristow SE, Neal DE. 1996. Ambulatory urodynamics. Br J Urol 77:333-338.
4. Moore KH, Hay DM, Imrie AE, et al. 1990. Oxybutynin hydrochloride (3 mg) in the treatment of women with idiopathic detrusor instability. Br J Urol 66:479-85.
5. Newgreen DT, Anderson CWP, Carter AJ, Naylor AM. 1995. Darifenacin - a novel bladder selective agent for the treatment of urge incontinence. Neurourol Urodynam 214:555-557.
6. Porru D, Usai E. 1994. Standard and extramural ambulatory urodynamic investigation for the diagnosis of detrusor instability-correlated incontinence and micturition disorders. Neurourol Urodynam 13:237-42.
7. Riva D, Casolati E. 1984. Oxybutynin chloride in the treatment of female idiopathic detrusor instability. Results from double blind treatment. Clin Exp Obstet Gynecol 11:37-42.
8. Robertson AS, Griffiths CJ, Ramsden PD, Neal DE. 1994. Bladder function in healthy volunteers: ambulatory monitoring and conventional urodynamic studies. Br J Urol 73:242-9.
9. Styles RA, Nea DE, Ramsden PD. 1986. Comparison of long term monitoring and standard cystometry in chronic retention of urine. Br J Urol 58:652-656.
10. Tapp AJ, Cardozo LD, Versi E, et al. 1990. The treatment of detrusor instability in post-menopausal women with oxybutynin hydrochloride: a double blind placebo controlled trial. Br J Obstet Gynaecol 97:521-26.
11. Thuroff JW, Bunke B, Ebner A, Faber P, de Geeter P, Hannappel J, Heidler H, Madersbacher H, Melchior H, Schäfer W, et al. 1991. Randomised, double-blind, multicentre trial on treatment of frequency, urgency and incontinence related to detrusor hyperactivity: oxybutynin Vs propantheline Vs placebo. J Urol 145:813-7.
12. van Waalwijk van Doorn ESC, Zwiers W. 1990. Ambulant monitoring to assess the efficacy of oxybutynin chloride in patients with mixed incontinence. Eur Urol 18:49-51.
13. van Waalwijk van Doorn ES, Remmers A, Janknegt RA. 1992. Conventional and extramural ambulatory urodynamic testing of the lower urinary tract in female volunteers. J Urol 147:1319-25.
14. van Waalwijk van Doorn ESC, Malone-Lee JG, Janknegt RA. 1995. The differentiation of normal and abnormal contractions on ambulatory urodynamics. Neurourol Urodynam 14:531-532.
15. Webb RJ, Griffiths CJ, Ramsden PD, Neal DE. 1991. Ambulatory monitoring and electronic measurement of urinary leakage in the diagnosis of detrusor instability and incontinence. Br J Urol 68:148-152.
16. Yarker YE, Goa KL, Fitton A. 1995. Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability. Drugs Aging 6:243-262.